Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Syndromic surveillance insights from a symptom assessment app before and during COVID-19 measures in Germany and the United Kingdom: results from repeated cross-sectional analyses

Alicia Mehl, Francois Bergey, Caoimhe Cawley, Andreas Gilsdorf
doi: https://doi.org/10.1101/2020.06.16.20126466
Alicia Mehl
1Ada Health GmbH, Karl-Liebknecht-Str. 1, 10178 Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francois Bergey
1Ada Health GmbH, Karl-Liebknecht-Str. 1, 10178 Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Caoimhe Cawley
1Ada Health GmbH, Karl-Liebknecht-Str. 1, 10178 Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andreas Gilsdorf
1Ada Health GmbH, Karl-Liebknecht-Str. 1, 10178 Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Unprecedented lockdown measures have been introduced in countries across the world to mitigate the spread and consequences of COVID-19. While attention has focused on the effects of these measures on epidemiological indicators relating directly to the infection, there is increased recognition of their broader health implications. However, assessing these implications in real time is a challenge, due to limitations of existing syndromic surveillance data and tools.

Objective To explore the added value of mobile phone app-based symptom assessment tools as real time health insight providers to inform public health policy makers.

Methods A comparative and descriptive analysis of the proportion of all self-reported symptoms entered by users during an Ada assessment in Germany and the United Kingdom (UK) was conducted between two periods: before and after the implementation of “Phase One” COVID-19 measures. Additional analyses were performed to explore the association between symptom trends and seasonality, and symptom trends and weather. Differences in the proportion of unique symptoms between the periods were analysed using Pearson’s Chi-squared test and reported as Log2 Fold Changes (Log2 FC).

Results Between 48,300-54,900 symptomatic users reported 140,500-170,400 symptoms during the Baseline and Measures periods in Germany. Between 34,200-37,400 symptomatic users in the UK reported 112,100-131,900 symptoms during the Baseline and Measures periods. The majority of symptomatic users were female (Germany 68,600/103,200, 66.52%; UK 51,200/71,600, 72.74%). The majority (Germany 68,500/100,000, 68.45%; UK 50,900/68,800, 73.91%) were aged between 10 and 29 years, and about a quarter (Germany 26,200/100,000, 26.15%; UK 14,900/68,800, 21.65%) were between 30-59 years. 103 symptoms were reported either more or less frequently (with statistically significant differences) during the Measures as compared to the Baseline period, and 34 of these were found in both countries. The following mental health symptoms (Log2 FC, P-value) were reported less often during the Measures period: inability to manage constant stress and demands at work (−1.07, P<.001), memory difficulty (−0.56, P<.001), depressed mood (−0.42, P<.001), and impaired concentration (−0.46, P<.001). Diminished sense of taste (2.26, P<.001) and hyposmia (2.20, P<.001) were reported more frequently during the Measures period. None of the 34 symptoms were found to be different between the same dates in 2019. Fourteen of the 34 symptoms had statistically significant associations with weather variables.

Conclusions Symptom assessment apps have an important role to play in facilitating improved understanding of the implications of public health policies such as COVID-19 lockdown measures. Not only do they provide the means to complement and cross-validate hypotheses based on data collected through more traditional channels, they can also generate novel insights through a real-time syndromic surveillance system.

Competing Interest Statement

The authors are employees of Ada Health GmbH.

Funding Statement

This study was funded by Ada Health GmbH.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Clinical Governance Board of Ada Health has approved the ethical oversight of our study.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

When possible, data relevant to the study are included in the article or uploaded as supplementary information.

  • Abbreviations

    °C
    degrees Celsius
    COVID-19
    Coronavirus disease 2019
    GDPR
    General Data Protection Regulation
    ICD-10
    International Classification of Diseases version 2019
    Log2 F
    Log2 Fold Change
    mm
    millimeters
    P-value
    probability value
    UK
    United Kingdom
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted June 19, 2020.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Syndromic surveillance insights from a symptom assessment app before and during COVID-19 measures in Germany and the United Kingdom: results from repeated cross-sectional analyses
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Syndromic surveillance insights from a symptom assessment app before and during COVID-19 measures in Germany and the United Kingdom: results from repeated cross-sectional analyses
    Alicia Mehl, Francois Bergey, Caoimhe Cawley, Andreas Gilsdorf
    medRxiv 2020.06.16.20126466; doi: https://doi.org/10.1101/2020.06.16.20126466
    Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    Citation Tools
    Syndromic surveillance insights from a symptom assessment app before and during COVID-19 measures in Germany and the United Kingdom: results from repeated cross-sectional analyses
    Alicia Mehl, Francois Bergey, Caoimhe Cawley, Andreas Gilsdorf
    medRxiv 2020.06.16.20126466; doi: https://doi.org/10.1101/2020.06.16.20126466

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Epidemiology
    Subject Areas
    All Articles
    • Addiction Medicine (62)
    • Allergy and Immunology (142)
    • Anesthesia (46)
    • Cardiovascular Medicine (412)
    • Dentistry and Oral Medicine (69)
    • Dermatology (47)
    • Emergency Medicine (142)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (171)
    • Epidemiology (4843)
    • Forensic Medicine (3)
    • Gastroenterology (183)
    • Genetic and Genomic Medicine (674)
    • Geriatric Medicine (70)
    • Health Economics (192)
    • Health Informatics (626)
    • Health Policy (318)
    • Health Systems and Quality Improvement (203)
    • Hematology (85)
    • HIV/AIDS (156)
    • Infectious Diseases (except HIV/AIDS) (5326)
    • Intensive Care and Critical Care Medicine (328)
    • Medical Education (93)
    • Medical Ethics (25)
    • Nephrology (75)
    • Neurology (685)
    • Nursing (42)
    • Nutrition (114)
    • Obstetrics and Gynecology (126)
    • Occupational and Environmental Health (205)
    • Oncology (439)
    • Ophthalmology (140)
    • Orthopedics (36)
    • Otolaryngology (89)
    • Pain Medicine (35)
    • Palliative Medicine (16)
    • Pathology (129)
    • Pediatrics (194)
    • Pharmacology and Therapeutics (131)
    • Primary Care Research (84)
    • Psychiatry and Clinical Psychology (778)
    • Public and Global Health (1810)
    • Radiology and Imaging (323)
    • Rehabilitation Medicine and Physical Therapy (138)
    • Respiratory Medicine (255)
    • Rheumatology (86)
    • Sexual and Reproductive Health (69)
    • Sports Medicine (62)
    • Surgery (100)
    • Toxicology (23)
    • Transplantation (29)
    • Urology (37)